Zhiping Weng

UMassMed Faculty Page

Inventions:

Title: HIGH-AFFINITY DMF5 T CELL RECEPTOR (TCR) VARIANTS. UMMS13-50; Patent 9,717,758.

• The present invention provides amino and nucleic acid sequences for high-affinity variants of the DMF5 T-cell receptor.  Further, the invention provides methods of use for the treatment and imaging of melanoma in a patient. 

• Technology: Biologics
• Applications: Cancer, Melanoma

Innovation Topics: Biologics, Cancer, Melanoma